INDIANAPOLIS, Ind. (ADAMS) – Indianapolis-based pharmaceutical giant Eli Lilly says they have a shortage of two insulin products.
The company says the products are Humalog and Insulin Lispro Injection. Eli Lilly officials say they are “moving with urgency to address” the problem.
Read more here
Comments